RxSight, Inc. (RXST) Initiated at Market Perform as Firm Seeks Sales Reacceleration

We recently published an article titled 10 Best Long Term Healthcare Stocks to Buy. On January 30, William Blair initiated coverage of RxSight, Inc. (NASDAQ:RXST) with a Market Perform rating and no price target. The firm cited stalled sales growth in 2025 following strong adoption from early users between 2021 and 2024, noting that evidence of a sustained commercial reacceleration is needed despite the stock trading at a discount to peers. During its third-quarter 2025 earnings call, RxSight, Inc. (NAS ...